Nexus Pharmaceuticals opens state-of-the-art manufacturing facility

USA – Nexus Pharmaceuticals, a U.S.-based healthcare company and domestic pharmaceutical manufacturer, has opened Project Tomorrow, the company’s new, state-of-the-art manufacturing facility. The Wisconsin based facility will enable the company to expand its capability to deliver dependable, life-saving treatments to millions of patients in need. “Today marks another milestone in our company’s continued mission to manufacture specialty and generic injectables right here in America,” said Mariam S. Darsot, CEO and president, Nexus Pharmaceuticals. The Phase I investment of US$100 million supports a new, three-story manufacturing facility with cutting-edge technology, including…

Read More